Skip to main content
OpenTrials

Clinical trial condition

Non-Muscle Invasive Bladder Urothelial Carcinoma

Explore clinical trials studying Non-Muscle Invasive Bladder Urothelial Carcinoma. Study availability and eligibility vary by location and protocol.

12 public trials 8 recruiting studies
Refine in advanced search Browse all conditions

Non-Muscle Invasive Bladder Urothelial Carcinoma trial results

Recruiting

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

NCT06770582

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +11 more
Locations
  • Highlands Oncology Group - Fayetteville Fayetteville, Arkansas, United States
  • Highlands Oncology Group - Rogers Rogers, Arkansas, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
  • AIS Cancer Center at San Joaquin Community Hospital Bakersfield, California, United States
View all 134 locations
View Trial Details
Recruiting

A Randomized Trial of Bicalutamide in Non-Muscle Invasive Bladder Cancer

NCT05521698

Conditions
Non-Muscle Invasive Bladder Urothelial Carcinoma, Recurrent Non-Muscle Invasive Bladder Urothelial Carcinoma
Locations
  • University of Arizona Cancer Center - Prevention Research Clinic Tucson, Arizona, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • National Cancer Institute Urologic Oncology Branch Bethesda, Maryland, United States
  • University of Rochester Rochester, New York, United States
View Trial Details
Recruiting

A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer

NCT05483868

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +17 more
Locations
  • Arkansas Urology Little Rock, Arkansas, United States
  • Tower Urology Los Angeles, California, United States
  • Saint John's Cancer Institute Santa Monica, California, United States
  • Montefiore Medical Center The Bronx, New York, United States
View all 17 locations
View Trial Details
Recruiting

A Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder Cancer

NCT06503614

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +14 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
  • Weill Cornell Medical Center New York, United States
View Trial Details

Related conditions